Aasly J, Storsaeter O, Nilsen G, Smevik O, Rinck P (1993) Minor structural brain changes in young drug abusers. A magnetic resonance study. Acta Neurol Scand 87:210–214
PubMed
CAS
Article
Google Scholar
Abush H, Akirav I (2012) Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS One 7:e31731
PubMed
PubMed Central
CAS
Article
Google Scholar
Agudelo M, Yndart A, Morrison M, Figueroa G, Munoz K, Samikkannu T, Nair MP (2013) Differential expression and functional role of cannabinoid genes in alcohol users. Drug Alcohol Depend 133:789–793
PubMed
CAS
Article
Google Scholar
Ahn K, McKinney MK, Cravatt BF (2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108:1687–1707
PubMed
PubMed Central
CAS
Article
Google Scholar
Alen F, Santos A, Moreno-Sanz G, Gonzalez-Cuevas G, Gine E, Franco-Ruiz L, Navarro M, Lopez-Moreno JA (2009) Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-d-aspartate receptors. Neuroscience 158:465–473
PubMed
CAS
Article
Google Scholar
Allsop DJ, Dunlop AJ, Saddler C, Rivas GR, McGregor IS, Copeland J (2014) Changes in cigarette and alcohol use during cannabis abstinence. Drug Alcohol Depend 138:54–60
PubMed
CAS
Article
Google Scholar
Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315–348
PubMed
CAS
Article
Google Scholar
Arnold JC, Topple AN, Hunt GE, McGregor IS (1998) Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. Eur J Pharmacol 354:9–16
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Hungund BL (1999a) Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. J Neurochem 72:522–528
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Hungund BL (1999b) Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Res 815:89–97
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Cooper TB, Hungund BL (1998a) Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res 793:212–218
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Cooper TB, Hungund BL (1998b) Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2. Biochem Pharmacol 55:515–521
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2000a) Stimulation of cannabinoid receptor agonist 2-arachidonoylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim Biophys Acta 1535:78–86
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2000b) Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim Biophys Acta 1535:78–86
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2003) Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur J Pharmacol 466:73–83
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Yalamanchili R, Cravatt BF, Cooper TB, Hungund BL (2006) Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. Neuropharmacology 50:834–844
PubMed
CAS
Article
Google Scholar
Basavarajappa BS, Ninan I, Arancio O (2008) Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. J Neurochem 107:1001–1013
PubMed
PubMed Central
CAS
Google Scholar
Baum-Baicker C (1985) The psychological benefits of moderate alcohol consumption: a review of the literature. Drug Alcohol Depend 15:305–322
PubMed
CAS
Article
Google Scholar
Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV (1995) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10:89–97
PubMed
CAS
Article
Google Scholar
Belgrave BE, Bird KD, Chesher GB, Jackson DM, Lubbe KE, Starmer GA, Teo RK (1979) The effect of (-) trans-delta9-tetrahydrocannabinol, alone and in combination with ethanol, on human performance. Psychopharmacology 62:53–60
PubMed
CAS
Article
Google Scholar
Blednov YA, Cravatt BF, Boehm SL 2nd, Walker D, Harris RA (2007) Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase. Neuropsychopharmacology 32:1570–1582
PubMed
CAS
Article
Google Scholar
Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, Orlando P, Battista G, Pagano E, Di Marzo V, Izzo AA (2013) Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol 85:1306–1316
PubMed
CAS
Article
Google Scholar
Bramness JG, Khiabani HZ, Morland J (2010) Impairment due to cannabis and ethanol: clinical signs and additive effects. Addiction 105:1080–1087
PubMed
Article
Google Scholar
Bystrowska B, Smaga I, Frankowska M, Filip M (2014) Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. Prog Neuropsychopharmacol Biol Psychiatry 50:1–10
PubMed
CAS
Article
Google Scholar
Caille S, Alvarez-Jaimes L, Polis I, Stouffer DG, Parsons LH (2007) Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci 27:3695–3702
PubMed
CAS
Article
Google Scholar
Cha YM, White AM, Kuhn CM, Wilson WA, Swartzwelder HS (2006) Differential effects of delta9-THC on learning in adolescent and adult rats. Pharmacol Biochem Behav 83:448–455
PubMed
CAS
Article
Google Scholar
Chait LD, Perry JL (1994) Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology 115:340–349
PubMed
CAS
Article
Google Scholar
Chiou LC, Hu SS, Ho YC (2013) Targeting the cannabinoid system for pain relief? Acta Anaesthesiol Taiwan 51:161–170
PubMed
Article
Google Scholar
Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706–1713
PubMed
CAS
Article
Google Scholar
Ciccocioppo R, Antonelli L, Biondini M, Perfumi M, Pompei P, Massi M (2002) Memory impairment following combined exposure to delta(9)-tetrahydrocannabinol and ethanol in rats. Eur J Pharmacol 449:245–252
PubMed
CAS
Article
Google Scholar
Cippitelli A, Bilbao A, Hansson AC, del Arco I, Sommer W, Heilig M, Massi M, Bermudez-Silva FJ, Navarro M, Ciccocioppo R, Rodriguez de Fonseca F (2005) Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci 21:2243–2251
PubMed
Article
Google Scholar
Cippitelli A, Bilbao A, Gorriti MA, Navarro M, Massi M, Piomelli D, Ciccocioppo R, Rodriguez de Fonseca F (2007) The anandamide transport inhibitor AM404 reduces ethanol self-administration. Eur J Neurosci 26:476–486
PubMed
Article
Google Scholar
Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Rodriguez de Fonseca F, Piomelli D, Ciccocioppo R (2008) Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Psychopharmacology 198:449–460
PubMed
CAS
Article
Google Scholar
Colombo G, Agabio R, Fa M, Guano L, Lobina C, Loche A, Reali R, Gessa GL (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol 33:126–130
CAS
Article
Google Scholar
Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, Carai MM, Gessa L (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology 159:181–187
PubMed
CAS
Article
Google Scholar
Consroe P, Carlini EA, Zwicker AP, Lacerda LA (1979) Interaction of cannabidiol and alcohol in humans. Psychopharmacology 66:45–50
PubMed
CAS
Article
Google Scholar
Consroe P, Sandyk R, Snider SR (1986) Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 30:277–282
PubMed
CAS
Article
Google Scholar
Croft RJ, Mackay AJ, Mills AT, Gruzelier JG (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373–379
PubMed
CAS
Article
Google Scholar
Dar MS (2014) Functional interaction and cross-tolerance between ethanol and Delta9-THC: possible modulation by mouse cerebellar adenosinergic A1/GABAergic-A receptors. Behav Brain Res 270:287–294
PubMed
CAS
Article
Google Scholar
de Bruin NM, Lange JH, Kruse CG, Herremans AH, Schoffelmeer AN, van Drimmelen M, De Vries TJ (2011) SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats. Behav Brain Res 217:408–415
PubMed
Article
CAS
Google Scholar
Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613
PubMed
CAS
Google Scholar
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946–1949
PubMed
CAS
Article
Google Scholar
Dubois S, Mullen N, Weaver B, Bedard M (2014) The combined effects of alcohol and cannabis on driving: impact on crash risk. Forensic Sci Int 248c:94–100
Google Scholar
Dyr W, Ligieza J, Kostowski W (2008) The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats. Alcohol 42:509–512
PubMed
CAS
Article
Google Scholar
Easton CJ, Mandel D, Babuscio T, Rounsaville BJ, Carroll KM (2007) Differences in treatment outcome between male alcohol dependent offenders of domestic violence with and without positive drug screens. Addict Behav 32:2151–2163
PubMed
Article
Google Scholar
Economidou D, Mattioli L, Cifani C, Perfumi M, Massi M, Cuomo V, Trabace L, Ciccocioppo R (2006) Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology 183:394–403
PubMed
CAS
Article
Google Scholar
Erdozain AM, Callado LF (2011) Involvement of the endocannabinoid system in alcohol dependence: The biochemical, behavioral and genetic evidence. Drug Alcohol Depend 117:102–110
PubMed
CAS
Article
Google Scholar
Fernandez-Espejo E, Viveros MP, Nunez L, Ellenbroek BA, Rodriguez de Fonseca F (2009) Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology 206:531–549
PubMed
CAS
Article
Google Scholar
Fernandez-Lopez D, Pradillo JM, Garcia-Yebenes I, Martinez-Orgado JA, Moro MA, Lizasoain I (2010) The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. Stroke 41:2956–2964
PubMed
CAS
Article
Google Scholar
Ferrer B, Bermudez-Silva FJ, Bilbao A, Alvarez-Jaimes L, Sanchez-Vera I, Giuffrida A, Serrano A, Baixeras E, Khaturia S, Navarro M, Parsons LH, Piomelli D, Rodriguez de Fonseca F (2007) Regulation of brain anandamide by acute administration of ethanol. Biochem J 404:97–104
PubMed
PubMed Central
CAS
Article
Google Scholar
Formukong EA, Evans AT, Evans FJ (1988) Analgesic and anti-inflammatory activity of constituents of cannabis Sativa L. Inflammation 4:361–371
Article
Google Scholar
Freedland CS, Poston JS, Porrino LJ (2000) Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67:265–270
PubMed
CAS
Article
Google Scholar
Freedland CS, Sharpe AL, Samson HH, Porrino LJ (2001) Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res 25:277–282
PubMed
CAS
Article
Google Scholar
Gallate JE, Saharov T, Mallet PE, McGregor IS (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370:233–240
PubMed
CAS
Article
Google Scholar
George DT, Herion DW, Jones CL, Phillips MJ, Hersh J, Hill D, Heilig M, Ramchandani VA, Geyer C, Spero DE, Singley ED, O’Malley SS, Bishai R, Rawlings RR, Kunos G (2010) Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology 208:37–44
PubMed
PubMed Central
CAS
Article
Google Scholar
Gillet C, Polard E, Mauduit N, Allain H (2001) Acting out and psychoactive substances: alcohol, drugs, illicit substances. Encephale 27:351–359
PubMed
CAS
Google Scholar
Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 107:10–23
Article
CAS
Google Scholar
Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002a) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73–81
PubMed
CAS
Article
Google Scholar
Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA (2002b) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend 66:77–84
PubMed
CAS
Article
Google Scholar
Gonzalez S, Fernández-Ruiz JJ, Sparpaglione V, Parolaro D, Ramos JA (2002c) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels. Drug Alcohol Depend 66:77–84
PubMed
CAS
Article
Google Scholar
Gonzalez S, Cebeira M, Fernandez-Ruiz J (2005) Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav 81:300–318
PubMed
CAS
Article
Google Scholar
Gordon E, Devinsky O (2001) Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 42:1266–1272
PubMed
CAS
Article
Google Scholar
Gutierrez-Lopez MD, Llopis N, Feng S, Barrett DA, O’Shea E, Colado MI (2010) Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. Br J Pharmacol 160:772–783
PubMed
PubMed Central
CAS
Article
Google Scholar
Hansen HS, Moesgaard B, Hansen HH, Petersen G (2000) N-Acylethanolamines and precursor phospholipids—relation to cell injury. Chem Phys Lipids 108:135–150
PubMed
CAS
Article
Google Scholar
Hansson AC, Bermudez-Silva FJ, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, Heilig M (2007) Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32:117–126
PubMed
CAS
Article
Google Scholar
Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563–583
PubMed
CAS
Google Scholar
Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003) Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462:125–132
PubMed
CAS
Article
Google Scholar
Hoaken PN, Stewart SH (2003) Drugs of abuse and the elicitation of human aggressive behavior. Addict Behav 28:1533–1554
PubMed
Article
Google Scholar
Hohmann AG, Herkenham M (2000) Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse 37:71–80
PubMed
CAS
Article
Google Scholar
Houchi H, Babovic D, Pierrefiche O, Ledent C, Daoust M, Naassila M (2005) CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 30:339–349
PubMed
CAS
Article
Google Scholar
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161–202
PubMed
CAS
Article
Google Scholar
Huang SM, Bisogno T, Petros TJ, Chang SY, Zavitsanos PA, Zipkin RE, Sivakumar R, Coop A, Maeda DY, De Petrocellis L, Burstein S, Di Marzo V, Walker JM (2001) Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 276:42639–42644
PubMed
CAS
Article
Google Scholar
Hungund BL, Basavarajappa BS (2000) Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence. Alcohol Alcohol 35:126–133
PubMed
CAS
Article
Google Scholar
Ironside R, Bosanquet FD, McMenemy WH (1961) Central demyelination of the corpus callosum (Marchiafava-Bignami disease). With report of a second case in Great Britain. Brain 84:212–217
PubMed
CAS
Article
Google Scholar
Jeong WI, Osei-Hyiaman D, Park O, Liu J, Batkai S, Mukhopadhyay P, Horiguchi N, Harvey-White J, Marsicano G, Lutz B, Gao B, Kunos G (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7:227–235
PubMed
CAS
Article
Google Scholar
Kannel WB, Ellison RC (1996) Alcohol and coronary heart disease: the evidence for a protective effect. Clin Chim Acta 246:59–76
PubMed
CAS
Article
Google Scholar
Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE (1975) Effects of delta9-tetrahydrocannabinol and cannabinol in man. Pharmacology 13:502–512
PubMed
CAS
Article
Google Scholar
Kelly AB, Evans-Whipp TJ, Smith R, Chan GC, Toumbourou JW, Patton GC, Hemphill SA, Hall WD, Catalano RF (2015) A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion. Addiction 110:627–635
PubMed
Article
Google Scholar
Kinsey SG, Mahadevan A, Zhao B, Sun H, Naidu PS, Razdan RK, Selley DE, Imad Damaj M, Lichtman AH (2011) The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology 60:244–251
PubMed
PubMed Central
CAS
Article
Google Scholar
Klatsky AL (2007) Alcohol, cardiovascular diseases and diabetes mellitus. Pharmacol Res 55:237–247
PubMed
CAS
Article
Google Scholar
Korcha RA, Cherpitel CJ, Witbrodt J, Borges G, Hejazi-Bazargan S, Bond JC, Ye Y, Gmel G (2014) Violence-related injury and gender: the role of alcohol and alcohol combined with illicit drugs. Drug Alcohol Rev 33:43–50
PubMed
PubMed Central
Article
Google Scholar
Lallemand F, de Witte P (2005) Ethanol induces higher BEC in CB1 cannabinoid receptor knockout mice while decreasing ethanol preference. Alcohol Alcohol 40:54–62
PubMed
CAS
Article
Google Scholar
Lallemand F, De Witte P (2006) SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats. Alcohol 39:125–134
PubMed
CAS
Article
Google Scholar
Lamarque S, Taghzouti K, Simon H (2001) Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction. Neuropharmacology 41:118–129
PubMed
CAS
Article
Google Scholar
Lapoint J, James LP, Moran CL, Nelson LS, Hoffman RS, Moran JH (2011) Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila) 49:760–764
CAS
Article
Google Scholar
Leggett JD, Aspley S, Beckett SR, D’Antona AM, Kendall DA (2004) Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol 141:253–262
PubMed
PubMed Central
CAS
Article
Google Scholar
Lehtonen M, Storvik M, Tupala E, Hyytia P, Tiihonen J, Callaway JC (2010) Endogenous cannabinoids in post-mortem brains of Cloninger type 1 and 2 alcoholics. Eur Neuropsychopharmacol 20:245–252
PubMed
CAS
Article
Google Scholar
Lemon CH, Brasser SM, Smith DV (2004) Alcohol activates a sucrose-responsive gustatory neural pathway. J Neurophysiol 92:536–544
PubMed
CAS
Article
Google Scholar
Liang C, McClean MD, Marsit C, Christensen B, Peters E, Nelson HH, Kelsey KT (2009) A population-based case-control study of marijuana use and head and neck squamous cell carcinoma. Cancer Prev Res (Phila) 2:759–768
Article
Google Scholar
Lile JA, Kelly TH, Hays LR (2010) Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating delta9-tetrahydrocannabinol. Clin Neuropharmacol 33:235–242
PubMed
CAS
Article
Google Scholar
Linsenbardt DN, Boehm SL 2nd (2009) Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6 J mice: involvement of the posterior ventral tegmental area. Neuroscience 164:424–434
PubMed
PubMed Central
CAS
Article
Google Scholar
Lisdahl KM, Gilbart ER, Wright NE, Shollenbarger S (2013) Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry. doi:10.3389/fpsyt.2013.00053
PubMed
PubMed Central
Google Scholar
Lopez-Moreno JA, Gonzalez-Cuevas G, Rodriguez de Fonseca F, Navarro M (2004) Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. J Neurosci 24:8245–8252
PubMed
CAS
Article
Google Scholar
Louvet A, Teixeira-Clerc F, Chobert MN, Deveaux V, Pavoine C, Zimmer A, Pecker F, Mallat A, Lotersztajn S (2011) Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 54:1217–1226
PubMed
CAS
Article
Google Scholar
LoVerme J, Duranti A, Tontini A, Spadoni G, Mor M, Rivara S, Stella N, Xu C, Tarzia G, Piomelli D (2009) Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice. Bioorg Med Chem Lett 19:639–643
PubMed
PubMed Central
CAS
Article
Google Scholar
Machado Rocha FC, Stefano SC, De Cassia Haiek R, Rosa Oliveira LM, Da Silveira DX (2008) Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl) 17:431–443
CAS
Article
Google Scholar
Mahmood OM, Jacobus J, Bava S, Scarlett A, Tapert SF (2010) Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects. J Stud Alcohol Drugs 71:885–894
PubMed
PubMed Central
Article
Google Scholar
Maida V, Ennis M, Irani S, Corbo M, Dolzhykov M (2008) Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. J Support Oncol 6:119–124
PubMed
CAS
Google Scholar
Marinho EA, Oliveira-Lima AJ, Santos R, Hollais AW, Baldaia MA, Wuo-Silva R, Yokoyama TS, Takatsu-Coleman AL, Patti CL, Longo BM, Berro LF, Frussa-Filho R (2014) Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice. Prog Neuropsychopharmacol Biol Psychiatry 58c:22–31
Google Scholar
Masten SV, Guenzburger GV (2014) Changes in driver cannabinoid prevalence in 12 U.S. states after implementing medical marijuana laws. J Safety Res 50:35–52
PubMed
Article
Google Scholar
McLaughlin PJ, Delevan CE, Carnicom S, Robinson JK, Brener J (2000) Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav 66:803–809
PubMed
CAS
Article
Google Scholar
Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF (2007) Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol 29:141–152
PubMed
PubMed Central
CAS
Article
Google Scholar
Metrik J, Spillane NS, Leventhal AM, Kahler CW (2011) Marijuana use and tobacco smoking cessation among heavy alcohol drinkers. Drug Alcohol Depend 119:194–200
PubMed
PubMed Central
Article
Google Scholar
Midanik LT, Tam TW, Weisner C (2007) Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend 90:72–80
PubMed
PubMed Central
Article
Google Scholar
Mitrirattanakul S, Lopez-Valdes HE, Liang J, Matsuka Y, Mackie K, Faull KF, Spigelman I (2007) Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence. Alcohol Clin Exp Res 31:855–867
PubMed
CAS
Article
Google Scholar
Moreira FA, Crippa JA (2009) The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr 31:145–153
PubMed
Article
Google Scholar
Moreira FA, Wotjak CT (2010) Cannabinoids and anxiety. Curr Top Behav Neurosci 2:429–450
PubMed
Article
Google Scholar
Morgan CJ, Badway A (2009) Alcohol-induced euphoria: exclusion of serotonin. Alcohol Alcohol 36:22–25
Article
Google Scholar
Morisset V, Ahluwalia J, Nagy I, Urban L (2001) Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur J Pharmacol 429:93–100
PubMed
CAS
Article
Google Scholar
Müller-Vahl KR, Kolbe H, Schneider U, Emrich HM (1999) Cannabis in movement disorders. Forsch Komplementarmed 3:23–27
Article
Google Scholar
Myers J, Shetty N (2008) Going beyond efficacy: strategies for cancer pain management. Curr Oncol 15:S41–S49
PubMed
PubMed Central
CAS
Article
Google Scholar
Naassila M, Pierrefiche O, Ledent C, Daoust M (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46:243–253
PubMed
CAS
Article
Google Scholar
Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19:2987–2995
PubMed
CAS
Google Scholar
Narang S, Gibson D, Wasan AD, Ross EL, Michna E, Nedeljkovic SS, Jamison RN (2008) Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain 9:254–264
PubMed
CAS
Article
Google Scholar
Norstrom T (1998) Effects on criminal violence of different beverage types and private and public drinking. Addiction 93:689–699
PubMed
CAS
Article
Google Scholar
Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D (2007) Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain 133:210–220
PubMed
CAS
Article
Google Scholar
Oka S, Wakui J, Ikeda S, Yanagimoto S, Kishimoto S, Gokoh M, Nasui M, Sugiura T (2006) Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J Immunol 177:8796–8805
PubMed
CAS
Article
Google Scholar
Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann NY Acad Sci 1074:514–536
PubMed
CAS
Article
Google Scholar
Onaivi ES, Carpio O, Ishiguro H, Schanz N, Uhl GR, Benno R (2008) Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption. Ann NY Acad Sci 1139:426–433
PubMed
PubMed Central
CAS
Article
Google Scholar
Ortiz S, Oliva JM, Perez-Rial S, Palomo T, Manzanares J (2004) Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol 39:88–92
PubMed
CAS
Article
Google Scholar
Osilla KC, Pedersen ER, Ewing BA, Miles JN, Ramchand R, D’Amico EJ (2014) The effects of purchasing alcohol and marijuana among adolescents at-risk for future substance use. Subst Abuse Treat Prev Policy 9:38
PubMed
PubMed Central
Article
Google Scholar
Palmer E (2014) Sativex: ‘Life Changing’ cannabis-based multiple sclerosis drug rejected for use in England. http://www.ibtimes.co.uk/sativex-life-changing-cannabis-based-multiple-sclerosis-drug-rejected-use-england-1469080. Accessed 8 Oct 2014
Parolaro D, Vigano D, Realini N, Rubino T (2007) Role of endocannabinoids in regulating drug dependence. Neuropsychiatr Dis Treat 3:711–721
PubMed
PubMed Central
CAS
Google Scholar
Pava MJ, Woodward JJ (2012) A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. Alcohol 46:185–204
PubMed
PubMed Central
CAS
Article
Google Scholar
Pava MJ, Blake EM, Green ST, Mizroch BJ, Mulholland PJ, Woodward JJ (2012) Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. Psychopharmacology 219:137–147
PubMed
PubMed Central
CAS
Article
Google Scholar
Pavon FJ, Bilbao A, Hernandez-Folgado L, Cippitelli A, Jagerovic N, Abellan G, Rodriguez-Franco MA, Serrano A, Macias M, Gomez R, Navarro M, Goya P, Rodriguez de Fonseca F (2006) Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole–LH 21. Neuropharmacology 51:358–366
PubMed
CAS
Article
Google Scholar
Pennings EJ, Leccese AP, Wolff FA (2002) Effects of concurrent use of alcohol and cocaine. Addiction 97:773–783
PubMed
Article
Google Scholar
Peters EN, Hughes JR (2010) Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence. Drug Alcohol Depend 106:111–118
PubMed
Article
Google Scholar
Pina MM, Cunningham CL (2014) Effects of the novel cannabinoid CB1 receptor antagonist PF 514273 on the acquisition and expression of ethanol conditioned place preference. Alcohol 48:427–431
PubMed
PubMed Central
CAS
Article
Google Scholar
Pinder RM, Sandler M (2004) Alcohol, wine and mental health: focus on dementia and stroke. J Pharmacol 18:449–456
CAS
Google Scholar
Poncelet M, Maruani J, Calassi R, Soubrie P (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343:216–218
PubMed
CAS
Article
Google Scholar
Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301:1020–1024
PubMed
CAS
Article
Google Scholar
Pridemore WA (2004) Weekend effects on binge drinking and homicide: the social connection between alcohol and violence in Russia. Addiction 99:1034–1041
PubMed
PubMed Central
Article
Google Scholar
Ramaekers JG, Robbe HW, O’Hanlon JF (2000) Marijuana, alcohol and actual driving performance. Hum Psychopharmacol 15:551–558
PubMed
Article
Google Scholar
Rimondini R, Arlinde C, Sommer W, Heilig M (2002) Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J 16:27–35
PubMed
CAS
Article
Google Scholar
Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240–244
PubMed
CAS
Article
Google Scholar
Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC, Le Fur GL (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284:644–650
PubMed
CAS
Google Scholar
Rodriguez de Fonseca F, Roberts AJ, Bilbao A, Koob GF, Navarro M (1999) Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Acta Pharmacol Sin 20:1109–1114
CAS
Google Scholar
Ronen A, Chassidim HS, Gershon P, Parmet Y, Rabinovich A, Bar-Hamburger R, Cassuto Y, Shinar D (2010) The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks. Accid Anal Prev 42:1855–1865
PubMed
Article
Google Scholar
Rubbie D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the nucleus accumbens. J Neurosci 21:109–116
Google Scholar
Rubio M, McHugh D, Fernandez-Ruiz J, Bradshaw H, Walker JM (2007) Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. Neurosci Lett 421:270–274
PubMed
PubMed Central
CAS
Article
Google Scholar
Rubio M, Fernandez-Ruiz J, de Miguel R, Maestro B, Michael Walker J, Ramos JA (2008) CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. Neuropharmacology 54:976–988
PubMed
CAS
Article
Google Scholar
Rubio M, de Miguel R, Fernandez-Ruiz J, Gutierrez-Lopez D, Carai MA, Ramos JA (2009) Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas. Drug Alcohol Depend 99:354–358
PubMed
CAS
Article
Google Scholar
Rubio M, Villain H, Docagne F, Roussel BD, Ramos JA, Vivien D, Fernandez-Ruiz J, Ali C (2011) Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. PLoS One 6:e23690
PubMed
PubMed Central
CAS
Article
Google Scholar
Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092–1101
PubMed
PubMed Central
CAS
Article
Google Scholar
Sastre-Garriga J, Vila C, Clissold S, Montalban X (2011) THC and CBD oromucosal spray (Sativex(R)) in the management of spasticity associated with multiple sclerosis. Expert Rev Neurother 11:627–637
PubMed
CAS
Article
Google Scholar
Saults JS, Cowan N, Sher KJ, Moreno MV (2007) Differential effects of alcohol on working memory: distinguishing multiple processes. Exp Clin Psychopharmacol 15:576–587
PubMed
PubMed Central
Article
Google Scholar
Serra S, Brunetti G, Pani M, Vacca G, Carai MA, Gessa GL, Colombo G (2002) Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur J Pharmacol 443:95–97
PubMed
CAS
Article
Google Scholar
Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322–4334
PubMed
CAS
Google Scholar
Skrabek RQ, Galimova L, Ethans K, Perry D (2008) Nabilone for the treatment of pain in fibromyalgia. J Pain 9:164–173
PubMed
CAS
Article
Google Scholar
Smaga I, Bystrowska B, Gawlinski D, Pomierny B, Stankowicz P, Filip M (2014a) Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures. Neurotox Res 26:190–206
PubMed
PubMed Central
CAS
Article
Google Scholar
Smaga I, Bystrowska B, Gawlinski D, Przegalinski E, Filip M (2014b) The endocannabinoid/endovanilloid system and depression. Curr Neuropharmacol 12:462–474
PubMed
PubMed Central
CAS
Article
Google Scholar
Söderpalm B, Löf E, Ericson M (2009) Mechanistic studies of ethanol’s interaction with the mesolimbic dopamine reward system. Pharmacopsychiatry 42:S38–S94
Article
CAS
Google Scholar
Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann KF (2008) Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J Clin Psychopharmacol 28:317–324
PubMed
CAS
Article
Google Scholar
Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89–97
PubMed
CAS
Article
Google Scholar
Tapert SF, Granholm E, Leedy NG, Brown SA (2002) Substance use and withdrawal: neuropsychological functioning over 8 years in youth. J Int Neuropsychol Soc 8:873–883
PubMed
Article
Google Scholar
Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND (2005) Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 164:206–213
PubMed
CAS
Article
Google Scholar
Tramèr MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA, McQuay HJ (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323:16
PubMed
PubMed Central
Article
Google Scholar
Tucci SA, Halford JC, Harrold JA, Kirkham TC (2006) Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation. Curr Med Chem 13:2669–2680
PubMed
CAS
Article
Google Scholar
Ueda Y, Miyagawa N, Matsui T, Kaya T, Iwamura H (2005) Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur J Pharmacol 520:164–171
PubMed
CAS
Article
Google Scholar
Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D (2013) The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend 128:64–70
PubMed
PubMed Central
CAS
Article
Google Scholar
Vasiljevik T, Franks LN, Ford BM, Douglas JT, Prather PL, Fantegrossi WE, Prisinzano TE (2013) Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse. J Med Chem 56:4537–4550
PubMed
PubMed Central
CAS
Article
Google Scholar
Victor M, Adams RD, Mancall EL (1959) A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch Neurol 1:579–688
Article
Google Scholar
Victor M, Adams RD, Collins GH (1971) The Wernicke-Korsakoff syndrome: a clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 7:1–206
PubMed
CAS
Google Scholar
Vinod KY, Arango V, Xie S, Kassir SA, Mann JJ, Cooper TB, Hungund BL (2005) Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol Psychiatry 57:480–486
PubMed
CAS
Article
Google Scholar
Vinod KY, Yalamanchili R, Xie S, Cooper TB, Hungund BL (2006) Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem Int 49:619–625
PubMed
CAS
Article
Google Scholar
Vinod KY, Sanguino E, Yalamanchili R, Manzanares J, Hungund BL (2008a) Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol. J Neurochem 104:233–243
PubMed
CAS
Google Scholar
Vinod KY, Yalamanchili R, Thanos PK, Vadasz C, Cooper TB, Volkow ND, Hungund BL (2008b) Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice. Synapse 62:574–581
PubMed
PubMed Central
CAS
Article
Google Scholar
Vinod KY, Kassir SA, Hungund BL, Cooper TB, Mann JJ, Arango V (2010) Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. J Psychiatr Res 44:591–597
PubMed
PubMed Central
Article
Google Scholar
Vlachou S, Panagis G (2014) Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals. Curr Pharm Des 20:2072–2088
PubMed
CAS
Article
Google Scholar
Vonghia L, Leggio L, Ferrulli A, Bertini M, Gasbarrini G, Addolorato G (2008) Acute alcohol intoxication. Eur J Intern Med 19:561–567
PubMed
CAS
Article
Google Scholar
Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100:1393–1398
PubMed
PubMed Central
CAS
Article
Google Scholar
Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME (2008) Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects. Neuropsychopharmacology 33:653–665
PubMed
CAS
Article
Google Scholar
White AM (2003) What happened? Alcohol, memory blackouts, and the brain. Alcohol Res Health 27:186–196
PubMed
Google Scholar
Wilhelmsen K, Khakpour S, Tran A, Sheehan K, Schumacher M, Xu F, Hellman J (2014) The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. J Biol Chem 289:13079–13100
PubMed
PubMed Central
CAS
Article
Google Scholar
Wilson-Poe AR, Morgan MM, Aicher SA, Hegarty DM (2012) Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray. Neuroscience 213:191–200
PubMed
PubMed Central
CAS
Article
Google Scholar
Winward JL, Hanson KL, Tapert SF, Brown SA (2014) Heavy alcohol use, marijuana use, and concomitant use by adolescents are associated with unique and shared cognitive decrements. J Int Neuropsychol Soc 20:784–795
PubMed
Article
Google Scholar
World Health Organization (2012) World Drug Report. United Nations, New York
Google Scholar
Yang L, Rozenfeld R, Wu D, Devi LA, Zhang Z, Cederbaum A (2014) Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med 68:260–267
PubMed
PubMed Central
CAS
Article
Google Scholar
Zawilska JB, Wojcieszak J (2014) Spice/K2 drugs-more than innocent substitutes for marijuana. Int J Neuropsychopharmacol 17:509–525
PubMed
CAS
Article
Google Scholar
Zoethout RW, Delgado WL, Ippel AE, Dahan A, van Gerven JM (2011) Functional biomarkers for the acute effects of alcohol on the central nervous system in healthy volunteers. Br J Clin Pharmacol 71:331–350
PubMed
PubMed Central
CAS
Article
Google Scholar